• European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera ...
查看详情Guangzhou, China -- Bio-Thera Solutions, announced the initiation of a Phase III clinical trial evaluating the efficacy...
Bio-Thera Solutions, a global biopharmaceutical company today announced that the China National Drug Administration (CND...
July 25, 2018-- Bio-Thera Solutions, a clinical-stage pharmaceutical company, today announced that dosing has begun ina ...
